15 May 2002
Endothelin-1 gene polymorphism in the identification of patients at risk for malignant ventricular arrhythmia.
Lýdie Izákovicova Hollá, Milan Kozák, Lýdie Izákovicova Hollá, Lubomír Krivan, Anna Vasků, Milan Sepsi, Semrád Borivoj, Jirí VáchaMed Sci Monit 2002; 8(5): BR164-167 :: ID: 420852
Abstract
BACKGROUND: The endothelins are peptides with vasoconstricting and growth-promotingproperties. Endothelin-1 (ET-1) is known for its direct positive inotropic and chronotropic effects onisolated heart, and for growth effects. The aim of this pilot study was to investigate the frequencydistribution of a common polymorphism of the endothelin (ET-1) gene and its possible relation to thehemodynamic consequences of malignant ventricular arrhythmia in patients with structural heart disease.MATERIAL/METHODS: We studied 26 consecutive patients with malignant ventricular arrhythmia and implantablecardioverter defibrillators (ICD), mean age 62.7 +/- 12.2 years, mean LVEF 0.37 +/- 11. The Taq polymorphismof ET-1 was detected using our original PCR method. The PCR product with a length of 358 bp in its non-mutatedform contains a target sequence for the TaqI restrictive enzyme, while the mutated product loses thiscleavage site. RESULTS: Out of the 26 patients, 9 (34%) had recurrent palpitations and 8 (30.8%) hadsyncopes during their malignant arrhythmic episodes. 19 of the patients were receiving amiodarone afterICD implantation, 7 were not. 15 patients had the (++) and 11 had the (+ -) ET-1 genotype; none had the(- -) genotype. The risk of syncopes was associated with the (++) genotype (p=0.01). Patients with amiodaronehad a significantly higher frequency of the (++) genotype (p=0.011). CONCLUSIONS: All our results suggestedthat the presence of the (++)ET-1 genotype in patients with structural heart disease, severe left ventriculardysfunction, and malignant ventricular arrhythmia put these patients at a higher risk of hemodynamiccollapse during arrhythmic episodes.
Keywords: Arrhythmia, Endothelin-1, Genotype, Hemodynamic Processes, Heterozygote, Homozygote, Pilot Projects, Polymerase Chain Reaction, Polymorphism, Genetic
776 2
Editorial
01 November 2023 : Editorial
Editorial: Factors Driving New Variants of SARS-CoV-2, Immune Escape, and Resistance to Antiviral Treatments as the End of the COVID-19 Pandemic is DeclaredDOI: 10.12659/MSM.942960
Med Sci Monit 2023; 29:e942960
In Press
28 Nov 2023 : Clinical Research
Impact of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography on Therapeutic Decisions and ...Med Sci Monit In Press; DOI: 10.12659/MSM.942122
28 Nov 2023 : Clinical Research
Long-Term Outcomes of Decompression and Grafting in Acute Pathological Proximal Femur Fractures in Children...Med Sci Monit In Press; DOI: 10.12659/MSM.943031
27 Nov 2023 : Clinical Research
Comparison of Outcomes from Emergency Admissions to a Major Trauma Center in Turkey of 1646 Elderly Patient...Med Sci Monit In Press; DOI: 10.12659/MSM.942916
27 Nov 2023 : Clinical Research
Evaluating Modified Ultrasound-Guided Serratus Anterior Plane Block for Enhanced Postoperative Recovery in ...Med Sci Monit In Press; DOI: 10.12659/MSM.942757
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292